CELL THERAPEUTICS

Codice
CTIC.MI
Risorse esterne
Opinione della community
Prezzo Variazione Volume
3.032 +0.07 €
(+2.36%)
242
P/E Obiettivo ad 1anno
0 0 €

Compra - Vendi

0
Tutte le tue transazioni per questo titolo

Devi effettuare l'accesso


Grafico

Altri utenti che hanno investito

Transations in last week
Buy: 54
Sell : 20

lolibe Furio sony249 Fabrizio pierino Luca Aasi Dario Albieri Marco marco zorz

Commenti


Notizie

Brainstorm Cell Therapeutics (NASDAQ:BCLI) Receiving Somewhat Positive Media Coverage, Accern Reports - Sports Perspectives

Brainstorm Cell Therapeutics (BCLI) traded up 1.8326% during trading on Thursday, reaching $4.5621. 51,125 shares of the company's stock were exchanged. The firm's market cap is $85.47 million. Brainstorm Cell Therapeutics has a 12 month low of $2.06 ... Leggi

Dimension Therapeutics, Inc. (NASDAQ:DMTX) Sees Light Trading Volume with 13K Shares Changing Hands - Highlight Press

Dimension Therapeutics, Inc. shares had a trading volume of 13K by the end of trading on Friday. Trading volume was ... Its AAV manufacturing is performed in over two mammalian cell types, human embryonic kidney 293 cells (HEK293 cells) and HeLa cells. Leggi

Wall Street Stock Recommendations: Novo Nordisk A/S (NVO), Brainstorm Cell Therapeutics Inc. (BCLI) - Post Analyst

Novo Nordisk A/S (NYSE:NVO) was less active in the last trading session as around 0.91 million shares exchanged hands on Wall Street, representing a decrease from its normal capacity of 2.08 million shares. A 0.26% change after the initial price of $43 ...altro » Leggi

CytomX Therapeutics, Inc. (NASDAQ:CTMX) Experiences Heavier than Average Trading Volume - Highlight Press

Shares saw a steep increase in trading volume of 260.03% over the normal average daily volume. Short traders are feeling a little more bearish on shares of CytomX Therapeutics, Inc. of late as indicated by the increase in short interest. The firm ... Leggi

Brainstorm Cell Therapeutics Inc. (NASDAQ:BCLI) Moves -2.43% Over the Past 5 Days - Concord Register

Brainstorm Cell Therapeutics Inc. (NASDAQ:BCLI) closed at $4.42 after seeing 222307 shares trade hands during the most recent session. This represents a change of -1.78% from the opening. The shares have moved -2.43% on the week. The closing price ... Leggi

Vericel Corp (VCEL) Has Another Very Strong Trading Session - Finance News Daily

The stock of Vericel Corp (NASDAQ:VCEL) is a huge mover today! The stock increased 6.35% or $0.2 during the last trading session, reaching $3.35.altro » Leggi

EPS for Brainstorm Cell Therapeutics (BCLI) Expected At $-0.10; Treecom (TREE) Sentiment Is 1.21 - UtahHerald.com

The stock decreased 0.90% or $0.04 during the last trading session, reaching $4.42. About shares traded. Brainstorm Cell Therapeutics Inc (NASDAQ:BCLI) has risen 82.38% since July 18, 2016 and is uptrending. It has outperformed by 65.68% the S&P500. Leggi

Dimension Therapeutics, Inc. (NASDAQ:DMTX) Trading Volume Significantly Lower - Highlight Press

Dimension Therapeutics, Inc. shares had a trading volume of 10K by the end of trading on Wednesday. Shares saw a ... Its AAV manufacturing is performed in over two mammalian cell types, human embryonic kidney 293 cells (HEK293 cells) and HeLa cells. Leggi

Brainstorm Cell Therapeutics Inc. (NASDAQ:BCLI) Stock Rating Lowered by ValuEngine - StockNewsTimes

Shares of Brainstorm Cell Therapeutics (NASDAQ BCLI) traded up 0.68% on Friday, hitting $4.45. The stock had a trading volume of 78,723 shares. The stock's market cap is $83.37 million. Brainstorm Cell Therapeutics has a 12 month low of $2.06 and a 12 ...altro » Leggi

What's Sangamo Therapeutics Incorporated (NASDAQ:SGMO) Upside After This Short Interest Increase? - WeeklyHub

About shares traded. Sangamo Therapeutics Inc (NASDAQ:SGMO) has risen 29.78% since July 21, 2016 and is uptrending. It has outperformed by 13.08% the S&P500. Sangamo Therapeutics, Inc., formerly Sangamo BioSciences, Inc., is a clinical-stage ...altro » Leggi